Use our Project or Categories filter to narrow down your news search.

Reset

Decoding FDA DTC policy

SOUNDROCKET |
November 2018
G2P Blog

Scott D. Crawford, Shawn Fayer, and Robert C. Green directly address and highlight some of the recent FDA movement in the direct-to-consumer (DTC) genetic testing space with a five-post blog compilation.

The true cost of whole genome sequencing

Medium |
September 2018
G2P Blog

The true costs of genome sequencing don’t end with the technical production of A’s, T’s, C’s and G’s, and they don’t even end with the molecular interpretation of a few dozen or even a few hundred genes.

Genomic sequencing for newborns: Are parents receptive?

Boston Children's Hospital |
September 2018
G2P Blog

Casie Genetti, MS, CGC, a licensed genetic counselor with the Manton Center for Orphan Disease Research at Boston Children’s Hospital is first author of a recently published paper on the BabySeq Project and author of this blog about parents’ receptiveness to genome sequencing.

Genome sequencing for healthy people: Will it be harmful?

Medium |
March 2018
G2P Blog

The second piece of a 2-part blog series authored by Dr. Robert C. Green. An early study found no problems related to unnecessary or harmful medical follow-ups after healthy people received their genome sequencing results. To read the first piece, visit: https://medium.com/@genomes2people/genome-sequencing-for-healthy-people-will-it-be-helpful-b984b94e3d3f

Genome sequencing for healthy people: Will it be helpful?

Medium |
February 2018
G2P Blog

The first piece of a 2-part blog series authored by Dr. Robert C. Green. Early results suggest that yes, whole genome sequencing may very well be substantially helpful to a significant number of healthy patients. To read the second piece, visit: https://medium.com/@genomes2people/genome-sequencing-for-healthy-people-will-it-be-harmful-d915cc08e634

You didn’t ask for these genomic test results, but they might save your life

Huffington Post |
April 2017
G2P Blog

We found that almost exactly 1% of the populations in both FHS and JHS carried a pathogenic variant in one of the original ACMG56 genes. And we found that those carrying pathogenic variants had an increased aggregated risk of developing clinical features associated with the corresponding diseases.

Genome for healthy people: Early results

Huffington Post |
January 2017
G2P Blog

This is part of our overall scientific mission to determine how personal genomic sequencing may impact participants’ long-term health, behavioral and economic outcomes.

Genome sequencing for healthy people: Is it time?

The Huffington Post |
September 2016
G2P Blog

A blog post authored by Dr. Robert Green discussing the benefits and challenges that people and health professionals are faced with when dealing with genetic testing and screening. Here, he addresses ethical issues and potential complications alongside beneficial factors that deal genome testing.

Should researchers share genomic results with participants’ relatives?

Huffington Post |
May 2016
G2P Blog

“When researchers discover something about a participant that could significantly affect that person’s relatives, do the researchers have a duty to tell the relatives? Are the researchers bound to protect the participant’s privacy even if the participant is deceased?”

Motivations for personalized genetic testing include explaining – not just predicting

Huffington Post |
January 2016
G2P Blog

A blog post written by Robert Green addresses why people are motivated for continued with personalized genetic testing. “Our study suggested that the motivations for this interest go beyond simply predicting risk… and that for these participants, their fascination with genetics was an attempt to understand the condition that they had,” he says.

Genomic sequencing: Just another tool in the doctor’s bag

Huffington Post |
December 2015
G2P Blog

Dr. Robert Green digs deeper into his one of his own projects, MedSeq. He explains the motivation behind the project, his hopes for what will be achieved, and how this study will lead to helping other doctors understand how genomics will help their patients individually.

Latest News From Genomes2People